Pennsylvania

Students of color in Pa. are far less likely than their white peers to have access to small classes, certified teachers and advanced coursework, according to two studies.

Studies have shown that doctors at some hospitals routinely instruct medical students to perform practice exams on unconscious patients without their permission.

The eccentric personality had a lifelong love affair with his adopted city.

The head of a SEPTA division that is currently the subject of a federal corruption probe has been promoted to one of the highest ranking positions in the transit agency.

The chamber narrowly passed a measure that would require judges to issue consecutive sentences for multiple crimes involving guns.

More than 1.7 million Pennsylvanians use SNAP and the program contributes $2.5 billion dollars to the state’s economy.

Pennsylvania's second lady, Giselle Fetterman, will help lead a campaign to encourage residents to respond to the census.

At least 34 managers within SEPTA’s facility management unit have left the public transit agency in the wake of a federal investigation.

The partnership between Sandy Hook Promise and the state Attorney General's office aims to prevent mass shootings and help children dealing with problems.

Lyris Younge will stand trial before the Judicial Conduct Board. She's accused of violating parents due process rights in family court. Will she be removed?

The state used to cover a third of costs and now pays for a fourth of what districts spend on services for students with disabilities.

Postcard writing in groups has allegedly gained popularity since the election of President Donald Trump.

Starting Monday, Regional Rail riders will be able to tap their SEPTA Key Cards to exit at Jefferson Station weekdays from 6 a.m. to 8 p.m.

In order to change how congressional and state legislative districts are drawn before nationwide reapportionment in 2021, the General Assembly should set up a deal by January.

Their child, Benjamin, was the first baby born as part of Penn Medicine’s 2-year-old uterine transplant trial.